Drug major Glenmark Pharma said it has received final approval from the US health regulator for Dimethyl Fumarate delayed-release capsules, used for the treatment of relapsing forms of multiple sclerosis in adults.from Healthcare/Biotech-Industry-Economic Times https://ift.tt/2FbPzbo
via IFTTT
0 comments:
Post a Comment